COMMUNITY OUTREACH AND ENGAGEMENT ABSTRACT Cancer is the second leading cause of death in Utah, and Huntsman Cancer Institute (HCI) is the official Cancer Center of the State of Utah, pursuant to a 2005 legislative resolution. In recognition of this charge and the fact that >80% of HCI?s cancer patient population is from Utah, HCI defines its catchment area as the State of Utah. Further, HCI also serves as the only National Cancer Institute (NCI)-designated Cancer Center in the vast Mountain West region of the USA that includes Utah, Idaho, Montana, Nevada, and Wyoming. Through thoughtful monitoring of the cancer landscape in Utah, HCI has identified, invested in, and promoted research, prevention, and policy measures to address pressing needs of our catchment area, with the goal to achieve the greatest and most sustainable impact. Three primary focus areas of our efforts include: 1) Melanoma/Sun Safety: Utah has the highest melanoma incidence in the nation; 2) Lung Cancer/Tobacco Control/Radon Reduction: Lung cancer is the leading cause of cancer death in Utah; 3) Rural/Frontier and other Disparity Populations: Major opportunities to address cancer health equity due to Utah's rural/frontier geography and demographics. In addition, we have invested in areas with opportunities for innovation and impact based on features of our catchment area: 1) Top Five Cancers in Utah for Incidence or Mortality; 2) Inherited Cancer Risk; 3) Pediatric/Adolescent Cancers; 4) Prevention of HPV-Related Cancers. HCI?s Community Outreach and Engagement (COE) efforts encompass two major components. The Center for HOPE (Health Outcomes and Population Equity) leads our community-engaged and implementation research efforts to improve cancer-related population health, and the Community Outreach and Prevention Education office provides outreach and education about cancer risk, prevention, and care to patients and communities throughout Utah. HCI has an impressive portfolio of catchment-area relevant research, ranging from basic- science discovery and investigator-initiated clinical trials in our areas of focus, to a recently submitted Melanoma SPORE, and large team science grants that engage Utah?s Federally Qualified Health Centers. Finally, COE efforts align with our educational programs to address health equity, which include our CURE PathMaker Program and GMaP. HCI also works closely with two major community partners, HCI?s 38-member Community Advisory Board and the Utah Cancer Action Network, to establish priorities for services, outreach, education, and research. Through these and other state-wide and broader partnerships, HCI translates science to the community. We have been successful in achieving and continue to drive policy improvements at local and national levels, with particular emphasis on cancer-related topics of relevance to Utah.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935890
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Fuller, Andrew K; Bice, Benjamin D; Venancio, Ashlee R et al. (2018) A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model. J Vis Exp :
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Faham, Najme; Zhao, Ling; Welm, Alana L (2018) mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. NPJ Breast Cancer 4:36
Rengifo-Cam, William; Shepherd, Hailey M; Jasperson, Kory W et al. (2018) Colon Pathology Characteristics in Li-Fraumeni Syndrome. Clin Gastroenterol Hepatol 16:140-141
Solomon, Benjamin L; Garrido-Laguna, Ignacio (2018) Upper gastrointestinal malignancies in 2017: current perspectives and future approaches. Future Oncol 14:947-962
Gaffney, David K; Hashibe, Mia; Kepka, Deanna et al. (2018) Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol 151:547-554
Hardy, Christopher M; Burke, Molly K; Everett, Logan J et al. (2018) Genome-Wide Analysis of Starvation-Selected Drosophila melanogaster-A Genetic Model of Obesity. Mol Biol Evol 35:50-65
Gilcrease, Eddie B; Casjens, Sherwood R (2018) The genome sequence of Escherichia coli tailed phage D6 and the diversity of Enterobacteriales circular plasmid prophages. Virology 515:203-214
Park, Jihye; Blackburn, Brenna E; Rowe, Kerry et al. (2018) Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol 28:377-384
Fowler, Brynn; Ding, Qian; Pappas, Lisa et al. (2018) Utah Cancer Survivors: A Comprehensive Comparison of Health-Related Outcomes Between Survivors and Individuals Without a History of Cancer. J Cancer Educ 33:214-221

Showing the most recent 10 out of 1193 publications